Wall Street Journal Exclusive | AbbVie Near Deal for Revolution Medicines This post was originally published on this site. The cancer-drug biotech firm has a market value around $16 billion. By Jonathan D. Rockoff,Lauren Thomas,Cara LombardoJanuary 7, 2026No comment
